Product image of Minprostin (Dinoprostone) supplied by GNH India

Minprostin

Active Ingredient:
Dinoprostone
Origin:
EU

Minprostin (Dinoprostone)

Dinoprostone, the active ingredient in Minprostin, is a prostaglandin E2 analog presented as a vaginal formulation for intravaginal use. It is employed to soften the cervix and stimulate uterine contractions in obstetric settings.
GNH India supplies Minprostin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Pfizer Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Minprostin is a prostaglandin E2 analog used in obstetrics for cervical and uterine management.

  • Cervical ripening: softens and dilates the cervix to prepare for labor.
  • Induction of labor: initiates uterine contractions when labor needs to be started.
  • Medical termination of pregnancy: facilitates fetal expulsion in early pregnancy termination procedures.

How It Works

  • Dinoprostone binds to prostaglandin E2 (EP) receptors on cervical stromal cells and myometrial smooth muscle, activating intracellular cAMP pathways. This leads to collagen remodeling and cervical softening, while simultaneously increasing uterine contractility through enhanced calcium influx, promoting coordinated uterine contractions necessary for labor or termination.

Side Effects

Adverse reactions may occur with intravaginal dinoprostone use.

Common Side Effects

  • Uterine hyperstimulation: excessive contractions that may reduce fetal oxygenation.
  • Abdominal pain or cramping: discomfort in the lower abdomen.
  • Nausea and vomiting: gastrointestinal upset.
  • Diarrhea: loose stools.
  • Fever or chills: mild systemic response.
  • Vaginal bleeding: spotting or heavier flow.

Serious or Rare Side Effects

  • Uterine rupture: tearing of the uterine wall, a medical emergency.
  • Severe hemorrhage: significant blood loss requiring intervention.
  • Fetal distress: abnormal heart rate patterns.
  • Allergic reaction: rash, itching, or anaphylaxis.
  • Cardiovascular collapse: sudden drop in blood pressure.
  • Pulmonary edema: fluid accumulation in the lungs.

Precautions & Warnings

Clinicians should observe specific safety measures when using Minprostin.

  • Cervical assessment: evaluate readiness before administration.
  • Fetal monitoring: continuously monitor fetal heart rate during treatment.
  • Prior cesarean section: avoid or use with extreme caution due to rupture risk.
  • Multiple gestation: consider increased risk of hyperstimulation.
  • Placenta previa or abruptio placentae: contraindicated.
  • Store at room temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Dinoprostone may interact with other agents affecting uterine activity or prostaglandin pathways.

Major Interactions (Avoid)

  • Oxytocin: combined use can cause severe uterine hyperstimulation.
  • Misoprostol: additive prostaglandin effect may lead to excessive contractions.

Moderate Interactions (Monitor Closely)

  • Non‑steroidal anti‑inflammatory drugs (NSAIDs): may diminish dinoprostone efficacy.
  • Tocolytic agents (e.g., nifedipine): can antagonize uterine stimulation.
  • Anticoagulants: increased risk of bleeding during cervical ripening.
  • Beta‑agonists: may alter uterine response to prostaglandins.

Frequently Asked Questions

Minprostin contains dinoprostone, a prostaglandin E2 analog that is used in obstetrics to ripen the cervix, induce labor, and facilitate medical termination of early pregnancy by promoting cervical softening and uterine contractions.

Dinoprostone activates prostaglandin E2 receptors on cervical tissue and uterine muscle, triggering biochemical pathways that remodel cervical collagen and increase calcium‑mediated uterine contractility, thereby preparing the cervix for delivery and initiating labor.

The dose of Minprostin is determined by the prescribing clinician based on the patient’s obstetric condition, gestational age, and response to therapy. Specific dosing regimens are outlined in the product’s prescribing information.

Minprostin is intended for use during pregnancy to induce labor or terminate a pregnancy under medical supervision. It is not recommended for breastfeeding mothers because prostaglandins can be transferred into breast milk; clinicians should evaluate risks and benefits.

To order Minprostin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Minprostin (dinoprostone) is a prostaglandin E2 analog, whereas alternatives such as misoprostol are prostaglandin E1 analogs. Dinoprostone generally provides a more controlled cervical ripening effect with a lower risk of severe hyperstimulation compared with some other agents, but choice depends on clinical protocol and patient factors.

Minprostin should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain its stability and efficacy.

Minprostin is administered intravaginally, typically as a tablet or gel placed in the posterior fornix of the vagina. The exact method and frequency are determined by the treating physician according to clinical guidelines.

Serious risks include uterine hyperstimulation leading to fetal distress, uterine rupture, severe maternal hemorrhage, and rare allergic reactions. Continuous fetal monitoring and careful assessment of uterine activity are essential to mitigate these risks.

Minprostin is contraindicated in women with prior uterine surgery such as classical cesarean section, placenta previa, abruptio placentae, active vaginal bleeding, or hypersensitivity to prostaglandins. It should also be used with caution in multiple gestations and in patients with severe cardiac or renal disease.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dinoprostone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT